Home Applications 220018 Application 220018
Type NDA
Sponsor GILEAD SCIENCES INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 YEZTUGO LENACAPAVIR SODIUM SOLUTION;SUBCUTANEOUS EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) Yes Yes 002 YEZTUGO LENACAPAVIR SOLUTION;SUBCUTANEOUS 463.5MG/1.5ML(309MG/ML) No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220018-001 YEZTUGO LENACAPAVIR SODIUM EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2025-06-18
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220018-001 9951043 2034-02-28 U-4190 Drug substance, Drug product 2025-07-11 N220018-001 10071985 2037-08-17 Drug substance, Drug product 2025-07-11 N220018-001 11267799 2038-08-16 Drug substance 2025-07-11 N220018-001 12594267 2039-07-15 Drug product 2026-04-16 N220018-001 11807625 2040-11-25 U-4190 2025-07-11
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N220018-001 NCE 2027-12-22 N220018-001 NP 2028-06-18
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220018-001 YEZTUGO EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2025-06-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 YEZTUGO EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2025-06-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220018-001 YEZTUGO EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2025-06-18 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 YEZTUGO EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2025-06-18 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220018-001 9951043 2034-02-28 U-4190 Drug substance, Drug product 2025-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220018-001 10071985 2037-08-17 Drug substance, Drug product 2025-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220018-001 11267799 2038-08-16 Drug substance 2025-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220018-001 11807625 2040-11-25 U-4190 2025-07-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 9951043 2034-02-28 U-4190 Drug substance, Drug product 2025-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 10071985 2037-08-17 Drug substance, Drug product 2025-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 11267799 2038-08-16 Drug substance 2025-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 11807625 2040-11-25 U-4190 2025-07-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220018-001 9951043 2034-02-28 U-4190 Drug substance, Drug product 2025-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220018-001 10071985 2037-08-17 Drug substance, Drug product 2025-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220018-001 11267799 2038-08-16 Drug substance 2025-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220018-001 11807625 2040-11-25 U-4190 2025-07-11 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 9951043 2034-02-28 U-4190 Drug substance, Drug product 2025-07-11 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 10071985 2037-08-17 Drug substance, Drug product 2025-07-11 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 11267799 2038-08-16 Drug substance 2025-07-11 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 12594267 2039-07-15 Drug product 2026-04-16 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 11807625 2040-11-25 U-4190 2025-07-11 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220018-001 NCE 2027-12-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220018-001 NP 2028-06-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 NCE 2027-12-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220018-001 NP 2028-06-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220018-001 NCE 2027-12-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220018-001 NP 2028-06-18 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 NCE 2027-12-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220018-001 NP 2028-06-18 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Yeztugo LENACAPAVIR SODIUM Gilead Sciences, Inc. 1c241af1-ce62-4b0a-9eb7-f6b626174f01 2026-02-12 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 220018 application number: NDA220018
Documents# Document, Submission type, Date table Document Submission type Date 83977 ORIG 2025-10-29 82622 ORIG 2025-06-20 82609 ORIG 2025-06-20